Table 3.

Linear mixed model main effect results of quality-of-life outcomes across treatment and control groups, 6-month and 12-month follow-ups

Variables	Intervention (n = 76) Mean (SD)	Control (n = 77) Mean (SD)	p
Perceived Stress Scale
6-month follow-up	20.64 (7.61)	20.32 (8.31)
12-month follow-up	21.59 (7.44)	20.01 (8.23)	.01
Social Well-Being (SWB) sub-scale
6-month follow-up	20.96 (5.37)	20.54 (5.94)
12-month follow-up	20.77 (5.15)	20.46 (6.17)	.77
Emotional Well-Being (EWB) sub-scale
6-month follow-up	20.91 (2.75)	19.97 (3.67)
12-month follow-up	20.22 (3.23)	19.76 (3.98)	.76
Functional Well-Being (FWB) sub-scale
6-month follow-up	21.76 (4.29)	20.71 (5.24)
12-month follow-up	20.60 (4.68)	20.78 (5.42)	.98
Physical Well-Being (PWB) sub-scale
6-month follow-up	24.13 (3.91)	23.25 (4.42)
12-month follow-up	23.60 (4.09)	23.57 (4.13)	.62
FACT-G
6-month follow-up	87.96 (12.48)	84.47 (15.81)
12-month follow-up	85.21 (13.38)	84.57 (16.42)	.41
BCS*
6-month follow-up	25.01 (5.38)	24.15 (5.86)
12-month follow-up	24.77 (5.34)	24.31 (6.37)	.82
TOI**
6-month follow-up	71.11 (11.32)	68.12 (12.67)
12-month follow-up	68.98 (11.51)	68.67 (13.60)	.40
CES-D
6-month follow-up	2.45 (2.18)	2.65 (2.39)
12-month follow-up	2.85 (2.74)	2.88 (2.70)	.51

^*BCS, Breast Cancer Scale;

^**TOI, Trial Outcome Index = PWB + FWB + BCS; FACTG = PWB + SWB + EWB + FWB. FACT-B encompasses FACTG + BCS